Abdul Rafeh Naqash, MD

Abdul Rafeh Naqash is an advanced fellow in the Early Clinical Trials Development Program and the Developmental Therapeutics Clinic at the National Cancer Institute, Bethesda.

After receiving his medical degree at the Government Medical College Srinagar, Kashmir, Dr. Naqash pursued short-term research training at the National Institute of Immunology, New Delhi, and at the University of Buffalo, NY. He completed Internal Medicine residency training at the University of Buffalo/Catholic Health. Subsequently, Dr. Naqash completed his sub-specialty clinical training in Hematology/Oncology at East Carolina University, Greenville, NC. At the NCI, developmental therapeutics clinic Dr. Naqash is focusing his interest in drug development and incorporating a genomically driven approach to early phase clinical trials. He is also interested in immunotherapy biomarkers and immune toxicities. Dr. Naqash has been the recipient of several national awards, including the ASCO-SITC merit awards in 2018 and 2019, and the 2020 ASCO- Young Investigator Award. He was one of the 33 nationally selected early career investigators for the 2018 SITC Sparkathon. Dr. Naqash is an executive member of the SITC Early Career Scientist Committee and the ASCO Trainee and Early Career Council, where he is actively involved in working towards developing educational initiatives for early-career investigators.

Outside of work, Dr. Naqash enjoys traveling and spending time with this wife and eighteen-month-old daughter.